selegiline HCl

selegiline HCl (silej´əlēn),

n brand names: Eldepryl, SD-Deprenyl;
drug class: antiparkinson agent;
action: increased dopaminergic activity by inhibiting monoamine oxidase (MAO) type B activity;
uses: adjunct management of Parkinson's disease in patients being treated with carbidopa-levodopa.
References in periodicals archive ?
The drug Anipryl (also known as selegiline HCL or L-deprenyl), developed to treat Parkinson's disease in humans, was approved by the FDA in 1999 for use as a treatment for CCD.